Literature DB >> 6968341

Hypercalcaemia associated with cerebral vasospasm causing infarction.

G L Walker, P M Williamson, R B Ravich, J Roche.   

Abstract

Central nervous system disorders are not uncommon in patients with hyperparathyroidism and hypercalcaemia. Usually these consist of neuropsychiatric disturbances but acute encephalopathies and seizures may occur. A rare manifestation is cerebral infarction. A patient is presented with neuroradiological evidence of infarction caused by cerebral arterial spasm which appears related to hypercalcaemia due to hypervitaminosis D. Arterial spasm is suggested as a possible aetiological factor in focal neurological lesions associated with hypercalcaemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968341      PMCID: PMC490578          DOI: 10.1136/jnnp.43.5.464

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  NEUROPSYCHIATRIC DISORDERS IN PRIMARY HYPERPARATHYROIDISM. CLINICAL ANALYSIS WITH REVIEW OF THE LITERATURE.

Authors:  G KARPATI; B FRAME
Journal:  Arch Neurol       Date:  1964-04

2.  Hypertensive encephalopathy in a child.

Authors:  V Fentz
Journal:  Acta Neurol Scand       Date:  1962       Impact factor: 3.209

3.  Neuropsychiatric presentation of hypercalcemia.

Authors:  G M LEHRER; M F LEVITT
Journal:  J Mt Sinai Hosp N Y       Date:  1960 Jan-Feb

4.  Increased spinal fluid protein in hyperparathyroidism and other hypercalcemic states.

Authors:  G A EDWARDS; S M DAUM
Journal:  AMA Arch Intern Med       Date:  1959-07

5.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

6.  Epileptiform fits during calciferol therapy.

Authors:  J M BEARE; J H D MILLAR
Journal:  Lancet       Date:  1951-04-21       Impact factor: 79.321

7.  Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries.

Authors:  G S Allen; L M Henderson; S N Chou; L A French
Journal:  J Neurosurg       Date:  1974-04       Impact factor: 5.115

Review 8.  Vascular smooth muscle. I. Normal structure, pathology, biochemistry, and biophysics.

Authors:  A P Somlyo; A V Somlyo
Journal:  Pharmacol Rev       Date:  1968-12       Impact factor: 25.468

9.  Stroke in hyperparathyroidism.

Authors:  H Boström; A Alveryd
Journal:  Acta Med Scand       Date:  1972-10

10.  Less common manifestations of hyperparathyroidism.

Authors:  L Andersson; T Lindholm
Journal:  Acta Med Scand       Date:  1967-10
View more
  4 in total

1.  Parathyroid hormone in coronary artery disease--results of a prospective study.

Authors:  G Herrmann; R Hehrmann; H C Scholz; M Atkinson; P Lichtlen; A von zur Mühlen; R D Hesch
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

2.  Primary hyperparathyroidism presenting as unilateral visual loss.

Authors:  D Chappel; K Farrington
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  Elevated calcium after acute ischemic stroke: association with a poor short-term outcome and long-term mortality.

Authors:  Jong-Won Chung; Wi-Sun Ryu; Beom Joon Kim; Byung-Woo Yoon
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

Review 4.  The Role of Serum Calcium Level in Intracerebral Hemorrhage Hematoma Expansion: Is There Any?

Authors:  Mostafa Jafari; Mario Di Napoli; Yvonne H Datta; Eric M Bershad; Afshin A Divani
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.